Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chemokine receptors on dendritic cells are a group of G protein-coupled receptors (GPCRs) expressed on the surface of dendritic cells that enable them to sense and respond to chemokine gradients. Major examples include CCR7, which mediates the migration of mature dendritic cells to lymph nodes in response to CCL19/CCL21, and XCR1, which is uniquely expressed on cross-presenting dendritic cells and guides them via XCL1 ligands[1][2][3][6]. These receptors regulate essential dendritic cell functions such as chemotaxis, adhesion, survival, and immune activation, and are key to spatial and temporal coordination of immune responses[1][3][5]. Dysregulation of their expression or function is implicated in immune disorders, infections, and cancer. Because they represent nodal points in immune cell trafficking and activation, individual chemokine receptors (but not the entire group generically) are considered therapeutic targets for modulating immunity, improving vaccine efficacy, and controlling autoimmunity or tumor responses[1][5]. Note: The provided entry is NOT a single protein/receptor but rather a heterogeneous group of receptors that should be considered and curated individually (e.g., CCR7, XCR1)[3]. Each has unique properties, ligands, and roles in dendritic cell biology. The name "Chemokine receptors on dendritic cells" is overly broad and not a canonical target; structured information should be captured for individual chemokine receptors where possible.
Antagonism/inhibition of chemokine receptor signaling to block migration or activation Agonism to enhance dendritic cell migration or immune priming (research stage)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine receptor on dendritic cell (specific examples: e.g., CCR7, XCR1).